Androgen suppresses PML protein expression in prostate cancer CWR22R cells

Lin Yang1, Shauh-Der Yeh, Shaozhen Xie

  • 1George Whipple Lab for Cancer Research, Department of Pathology, The Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA.

Insights

Promyelocytic leukemia (PML) protein acts as a tumor suppressor in prostate cancer by inhibiting androgen receptor (AR) transactivation and enhancing p53 activity, thereby suppressing tumor cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Promyelocytic leukemia (PML) protein's role in modulating tumor suppressive pathways suggests its potential as a tumor suppressor.
  • The specific mechanisms of PML in prostate cancer progression are not fully understood.

Purpose of the Study:

  • To investigate the functional mechanism of PML in prostate cancer progression.
  • To elucidate the relationship between PML, androgen receptor (AR) transactivation, and p53 activity in prostate cancer cells.

Main Methods:

  • Utilized CWR22R prostate cancer cells to study PML protein expression under androgen influence.
  • Assessed the impact of PML on AR transactivation and p53 activity.
  • Examined the effect of PML on cell colony formation, including experiments with PML siRNA.

Main Results:

  • PML protein expression is suppressed by androgen in CWR22R prostate cancer cells.
  • PML selectively suppresses AR transactivation and positively correlates with p21 protein levels.
  • PML enhances p53 transcription ability, inhibits CWR22R cell colony formation, while PML siRNA increases AR activity and colony formation.

Conclusions:

  • PML functions as a tumor suppressor in prostate cancer.
  • PML inhibits prostate cancer cell growth by suppressing AR transactivation and/or enhancing p53 activity.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.